Navigation Links
Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market
Date:9/2/2009

CORAL GABLES, Fla., Sept. 2 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) has received approval from The NASDAQ Stock Market to transfer the listing of its common stock from The NASDAQ Global Market(R) to The NASDAQ Capital Market(R). The transfer will be effective at the opening of the market on September 3, 2009. Catalyst will continue to trade under the symbol "CPRX" with no impact on the ability of investors to trade the stock.

The NASDAQ Capital Market(R) is a continuous trading market that operates in the same manner as The NASDAQ Global Market(R). The NASDAQ Capital Market(R) includes the securities of approximately 450 companies. All companies listed on The NASDAQ Capital Market(R) must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. For more information about the Company, go to www.catalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including those disclosed in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.


'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
4. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
5. CATalyst Summit Declared a Success: Its All About the Cat!
6. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
9. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
10. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
11. CATalyst Council Forms to Address Feline Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Adelaide, Australia (PRWEB) , ... March 23, 2017 , ... ... As a nurse by profession, author Joy Nugent was inspired to write the book ... work came from her inward desire to make sense of what she was experiencing ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... Bay Area providing insurance assistance, financial planning, and related services to residents of ... International to promote awareness of threatened species and wild lands. , Endangered Species ...
(Date:3/22/2017)... California (PRWEB) , ... March 22, 2017 , ... Old ... British boxing champ Ashley Theophane as a new Brand Ambassador. Theophane, who trained with ... light welterweight title in 2011. He has racked up an impressive number of wins ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... digital and print media enterprise focused on cancer patients, cancer centers and advocacy ... a special 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... plan to cure Rett Syndrome, a devastating neurological disorder that afflicts 350,000 individuals ... located on the X chromosome, and almost exclusively strikes females. Following a ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... 2017 Serve You Rx Vermont, LLC, a wholly ... You), based in Milwaukee, Wisconsin , has ... in Middlebury, Vermont , from Pharmacy Health ... so it was perfect timing for this opportunity to present ... Serve You. "Like us, NEMOP has a high-touch service model, ...
(Date:3/22/2017)... 22. März 2017   VWR ... tätige Anbieter von Produkten und Dienstleistungen für ... von EPL Archives Inc. bekannt, eines internationalen ... im kompletten Zyklus regulierter Forschung, Entwicklung und ... Speicherung von Dokumenten und Zusatzdienstleistungen zur Seite ...
(Date:3/22/2017)... March 22, 2017 TapImmune, Inc. ... in the development of innovative peptide and gene-based ... disease, today announced that it will participate in ... Dr. Glynn Wilson , Chairman and CEO ... company,s business, clinical pipeline and partnering opportunities for ...
Breaking Medicine Technology: